Machine Learning-Based Factor Analysis of Carbohydrate Metabolism Compensation for TDM2 Patients.

Type 2 diabetes is one of the most common chronic diseases in the world. World Diabetes Federation experts predict that the diabetes patients' number by 2035 will increase by 205 million to reach 592 million. For health care, this diabetes type is one of the highest priority problems. This disease is associated with many concomitant diseases leading to early disability and high cardiovascular risk. A severity disease indicator is the degree of carbohydrate metabolism compensation. Decompensated and subcompensated carbohydrate metabolism patients have increased cardiovascular risks. Therefore, it is important to be able to select the right therapy to control carbohydrate metabolism. In this study, we propose a new method for selecting the optimal therapy automatically. The method includes creating personal optimal therapies. This kind of therapy has the highest probability of compensating carbohydrate metabolism for a patient within a six-month. The method includes models for predicting the results of different therapies. It is based on data from the previous medical history and current medical indicators of patients. This method provides high-quality predictions and medical recommendations. Therefore, medical professionals can use this method as part of the Support and Decision-Making Systems for working with T2DM patients.